These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Inhibitory profiles of captopril on matrix metalloproteinase-9 activity. Yamamoto D; Takai S; Miyazaki M Eur J Pharmacol; 2008 Jul; 588(2-3):277-9. PubMed ID: 18501888 [TBL] [Abstract][Full Text] [Related]
8. Blood pressure control by the renin-angiotensin system in normotensive subjects. Assessment by angiotensin converting enzyme and renin inhibition. Kiowski W; Linder L; Kleinbloesem C; van Brummelen P; Bühler FR Circulation; 1992 Jan; 85(1):1-8. PubMed ID: 1728438 [TBL] [Abstract][Full Text] [Related]
9. Effects of imidapril and captopril on streptozotocin-induced diabetic nephropathy in mice. Katoh M; Ohmachi Y; Kurosawa Y; Yoneda H; Tanaka N; Narita H Eur J Pharmacol; 2000 Jun; 398(3):381-7. PubMed ID: 10862828 [TBL] [Abstract][Full Text] [Related]
10. [Determination of the inhibitory activity of angiotensin-converting enzyme inhibitor captopril by high performance capillary electrophoresis]. Xin ZH; Ma HL; Wu SY; Dai CH Yao Xue Xue Bao; 2003 Nov; 38(11):843-5. PubMed ID: 14991998 [TBL] [Abstract][Full Text] [Related]
11. Effect of angiotensin converting enzyme inhibitors on tolerance of nitroglycerin. Fang Z; Li Y; Liu D; Li Y; Hao F; Liu Z Chin Med J (Engl); 1995 Dec; 108(12):919-22. PubMed ID: 8728945 [TBL] [Abstract][Full Text] [Related]
13. [Angiotensin-converting enzyme inhibitors as neutralizers of hydroxyl radical]. Mira ML; Silva MM; Queirós MJ; Manso C Rev Port Cardiol; 1992 May; 11(5):425-30. PubMed ID: 1325814 [TBL] [Abstract][Full Text] [Related]
14. Comparative effects of a novel angiotensin-converting enzyme inhibitor versus captopril on plasma angiotensins after myocardial infarction. Flores-Monroy J; Ferrario CM; Valencia-Hernández I; Hernández-Campos ME; Martínez-Aguilar L Pharmacology; 2014; 94(1-2):21-8. PubMed ID: 25171296 [TBL] [Abstract][Full Text] [Related]
15. Captopril prevention project--what shall we do about captopril and the risk of stroke? Fournier A; Pruna A; Esper NE; Makdassi R; Oprisiu R; Westeel PF; Mazouz H; Achard JM Nephrol Dial Transplant; 2000 Jan; 15(1):2-5. PubMed ID: 10607758 [No Abstract] [Full Text] [Related]
16. Orally administered angiotensin-converting enzyme-inhibitors captopril and isoleucine-proline-proline have distinct effects on local renin-angiotensin system and corticosterone synthesis in dextran sulfate sodium-induced colitis in mice. Salmenkari H; Holappa M; Forsgard RA; Korpela R; Vapaatalo H J Physiol Pharmacol; 2017 Jun; 68(3):355-362. PubMed ID: 28820392 [TBL] [Abstract][Full Text] [Related]
18. Captopril caused a far lesser reduction in serum angiotensin-converting enzyme (ACE). Pedersen HD; Koch J J Vet Intern Med; 1999; 13(1):76-7. PubMed ID: 10052068 [No Abstract] [Full Text] [Related]
19. Substrate dependence of angiotensin I-converting enzyme inhibition: captopril displays a partial selectivity for inhibition of N-acetyl-seryl-aspartyl-lysyl-proline hydrolysis compared with that of angiotensin I. Michaud A; Williams TA; Chauvet MT; Corvol P Mol Pharmacol; 1997 Jun; 51(6):1070-6. PubMed ID: 9187274 [TBL] [Abstract][Full Text] [Related]
20. Differential influences of angiotensin converting-enzyme inhibitors on the coronary circulation. van Gilst WH; Scholtens E; de Graeff PA; de Langen CD; Wesseling H Circulation; 1988 Jun; 77(6 Pt 2):I24-9. PubMed ID: 3286044 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]